Form D · Biotechnology
IMMUTEP Ltd
Sydney, Nsw, C3 · CIK 0001506184
Offering snapshot reported Jul 30, 2019 · SEC filing
- Reported sold
- $521K Offering amount: $521K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 17, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2019 | Initial | $520,674 | No comparison | 4 | SEC filing |
| Dec 21, 2018 | Initial | $5,200,000 | No comparison | 2 | SEC filing |
| Jul 14, 2017 | Initial | $4,999,409 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345322
Source: Form D, filed Jul 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Chamberlain | Director |
| Russell John Howard | Director |
| Pete Meyers | Director |
| Peter Meyers | Director |
| Deanne Miller | Executive |
| Frederic Triebel | Executive |
| Lucy Turnbull | Director |
| Marc Voigt | Director, Executive |
| Albert Wong | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Level 12, 95 Pitt Street
Sydney, Nsw, C3, 2000
Sydney, Nsw, C3, 2000